Found: 12
Select item for more details and to access through your institution.
Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations.
- Published in:
- Genome Medicine, 2022, v. 14, p. 1, doi. 10.1186/s13073-022-01074-2
- By:
- Publication type:
- Article
Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01074-2
- By:
- Publication type:
- Article
338 The Alabama Genomic Health Initiative: Integrating Genomic Medicine into Primary Care.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Personalizing Direct Oral Anticoagulant Therapy for a Diverse Population: Role of Race, Kidney Function, Drug Interactions, and Pharmacogenetics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 3, p. 585, doi. 10.1002/cpt.2714
- By:
- Publication type:
- Article
Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1368, doi. 10.1002/cpt.2408
- By:
- Publication type:
- Article
Translational Pharmacogenomics: Discovery, Evidence Synthesis and Delivery of Race‐Conscious Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 4, p. 909, doi. 10.1002/cpt.2357
- By:
- Publication type:
- Article
Opportunity for Genotype‐Guided Prescribing Among Adult Patients in 11 US Health Systems.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 1, p. 179, doi. 10.1002/cpt.2161
- By:
- Publication type:
- Article
Prostate Cancer-Derived Cathelicidin-Related Antimicrobial Peptide Facilitates Macrophage Differentiation and Polarization of Immature Myeloid Progenitors to Protumorigenic Macrophages.
- Published in:
- Prostate, 2016, v. 76, n. 7, p. 624, doi. 10.1002/pros.23155
- By:
- Publication type:
- Article
Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 12, p. e2029411, doi. 10.1001/jamanetworkopen.2020.29411
- By:
- Publication type:
- Article
Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 4, p. 662, doi. 10.1111/cts.13479
- By:
- Publication type:
- Article
Evaluation of population‐level pharmacogenetic actionability in Alabama.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 6, p. 2327, doi. 10.1111/cts.13097
- By:
- Publication type:
- Article
Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 2, p. 260, doi. 10.1111/cts.12714
- By:
- Publication type:
- Article